WHO Approves Bavarian Nordic’s Mpox Vaccine for Adolescents
The World Health Organization (WHO) has approved Bavarian Nordic’s mpox vaccine, Jynneos, for adolescents aged 12 to 17. This age
Continue ReadingJune 9, 2026
The World Health Organization (WHO) has approved Bavarian Nordic’s mpox vaccine, Jynneos, for adolescents aged 12 to 17. This age
Continue ReadingThe World Health Organization (WHO) has added the MVA-BN vaccine to its prequalification list as the first approved vaccine for
Continue Reading